Rebamipide mofetil

CAS No. 1527495-76-6

Rebamipide mofetil( —— )

Catalog No. M28710 CAS No. 1527495-76-6

Rebamipide mofetil is an orally active prodrug of Rebamipide which is a mucoprotective agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 79 Get Quote
5MG 132 Get Quote
10MG 205 Get Quote
25MG 385 Get Quote
50MG 575 Get Quote
100MG 801 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Rebamipide mofetil
  • Note
    Research use only, not for human use.
  • Brief Description
    Rebamipide mofetil is an orally active prodrug of Rebamipide which is a mucoprotective agent.
  • Description
    Rebamipide mofetil is an orally active prodrug of Rebamipide which is a mucoprotective agent.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    NO Synthase|MAO|Tyrosinase|inflammation
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1527495-76-6
  • Formula Weight
    483.94
  • Molecular Formula
    C25H26ClN3O5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (206.64 mM)
  • SMILES
    O=C(C(CC(c(cccc1)c1N1)=CC1=O)NC(c(cc1)ccc1Cl)=O)OCCN1CCOCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wang S, et al. Rapid discovery and identification of anti-inflammatory constituents from traditional Chinese medicine formula by activity index, LC-MS, and NMR. Sci Rep. 2016 Aug 8;6:31000.
molnova catalog
related products
  • Amfenac Sodium Monoh...

    Amfenac Sodium monohydrate is a non-steroidal analgesic anti-inflammatory drug with acetic acid moiety.

  • Polmacoxib

    Polmacoxib (CG-100649) is a novel NSAID proposed to inhibit both COX-2 and carbonic anhydrase (CA)-I/-II.

  • Niflumic acid

    Niflumic acid, a Ca2+-activated Cl- channel blocker, is an analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.